Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and Roflumilast N -Oxide

By Oliver von Richter  

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 613-622

Adis International

Access to resources Recommend Favorite

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease Not Affected by Co-Administration of Memantine: An Open-Label, Crossover, Single-Centre Study

By Shua-Haim Joshua  

Clinical Drug Investigation, Vol. 28, Iss. 6, 2008-01 ,pp. : 361-374

Adis International

Access to resources Recommend Favorite

Alfentanil-Induced Miosis as a Surrogate Measure of Alfentanil Pharmacokinetics in Patients with Mild and Moderate Liver Cirrhosis

By Baririan Nariné   Luc Van Obbergh   Desager Jean-Pierre   Verbeeck Roger K.   Wallemacq Pierre   Starkel Peter   Horsmans Yves  

Clinical Pharmacokinetics, Vol. 46, Iss. 3, 2007-01 ,pp. : 261-270

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Modelling of Roflumilast and Roflumilast N-Oxide by Total Phosphodiesterase-4 Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model

By Lahu Gezim   Hünnemeyer Andreas  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 589-606

Adis International

Access to resources Recommend Favorite

Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection

By Morse G.D.  

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite